What Buyers Look For in a Home Health Agency in 2026
On July 1, 2026, CMS released the Calendar Year 2027 Home Health Prospective Payment System proposed rule (CMS-1844-P), and for the first time in three years the headline number moved in the owner’s favor: a net increase of about 2.4 percent, roughly $420 million more in Medicare payments to home health agencies. If you own an agency and you have wondered what buyers look for in a home health agency before they make an offer, that rule is the backdrop for the answer. Relief on paper does not loosen the diligence. Deal volume has cooled, buyers have grown choosier, and the premium now goes to the agencies that remove risk rather than the ones that simply grow revenue.As of July 2026, home-based care M&A has clearly reset. Mertz Taggart counted 16 closed home-based care transactions in the second quarter of 2026, down from 27 in the first quarter and 29 in the second quarter of 2025. Fewer deals does not mean weaker demand. Well-capitalized platforms are still buying, and the two largest home-based care transactions on record closed inside this cycle. It means buyers are spending their capital more carefully, and they are paying up only where the numbers and the operations hold together. This guide walks through exactly what they score, what raises your multiple, what makes them walk, and how to get ready, all conditioned on the facts of your specific agency.
What do buyers look for in a home health agency in 2026?
Buyers look for durable, transferable cash flow: a home health agency whose earnings will survive the owner’s exit, hold up under payer and staffing pressure, and pass clean through regulatory diligence. Everything else is detail underneath that one idea. As of July 2026, sophisticated buyers score six things above all: payer mix, margin durability, staffing stability, compliance posture, referral diversification, and owner independence. An agency that reads well on all six clears diligence quickly and attracts competing offers. An agency that reads poorly on two or three of them either takes a discount or sits on the market.
The reason the list matters more now than it did two years ago is simple. When deal volume was higher, marginal agencies still traded because capital was chasing scale. In a cooler market, buyers can be selective, so the gap between a prepared agency and an unprepared one shows up directly in the price. The table below is the shorthand version of the scorecard buyers carry into a first meeting.
| What buyers reward | What buyers penalize |
|---|---|
| Balanced payer mix with limited single-payer concentration | Heavy reliance on one payer or a shrinking Medicare Advantage rate |
| Stable or rising adjusted EBITDA margin | Margins propped up by one-time items or aggressive add-backs |
| Caregiver and clinical turnover below the industry norm | Turnover at or above 75 to 80 percent with open requisitions |
| Clean survey history and a strong CMS star rating | Open ADRs, active audit findings, or a recent failed survey |
| Referrals spread across many sources | One or two referral relationships tied to the owner personally |
| Operations that run without the owner day to day | Owner is the top clinician, top biller, and top salesperson |
How does the CY2027 home health proposed rule affect what your agency is worth?
The CY2027 proposed rule stabilizes buyer underwriting because it ends three straight years of feared permanent cuts, but it does not hand operators a free pass. The net 2.4 percent update is built from a 3.1 percent market basket increase, reduced by a 1.0 percentage point productivity cut, plus a 0.3 percentage point outlier adjustment. Notably, CMS proposed no new permanent behavioral-adjustment cut for the first time in three years, which is the part buyers care about most because it lowers the reimbursement uncertainty baked into their models.
The caveat is that CMS also proposed to continue a temporary reduction of about 3.0 percent to the 30-day payment rate to satisfy budget-neutrality math tied to the Patient-Driven Groupings Model. In plain terms, the ceiling on rate risk is lower than owners feared, but the floor still rewards efficiency. An agency that already runs clean margins reads this rule as confirmation. An agency that leans on volume to cover thin margins reads it as pressure. The public comment period runs through August 31, 2026, so the final numbers can move, and any owner planning a sale should track the final rule rather than the proposal. You can read the specifics in the CMS CY2027 fact sheet and the industry reaction from Home Health Care News.
For a fuller breakdown of how reimbursement and market factors flow into a number, our companion piece on home health agency valuation in 2026 works through the mechanics.
What multiple do home health agencies sell for in 2026?
As of the second quarter of 2026, Medicare-certified home health agencies generally traded at about 7x to 10x adjusted EBITDA outside certificate-of-need states, and about 9x to 12x in CON-protected markets, according to Mertz Taggart’s Q2 2026 report. These are ranges, not promises. Where a specific agency lands inside a band, or above it, depends on payer mix, geographic footprint, staff retention, compliance history, and the durability of its referral relationships. The table below shows the current bands across the home-based care segments so you can see where skilled home health sits relative to its neighbors.
| Segment | Typical 2026 EBITDA multiple band | What pushes toward the top |
|---|---|---|
| Medicare-certified home health (non-CON) | 7x to 10x | Scale, clean compliance, diversified referrals |
| Medicare-certified home health (CON states) | 9x to 12x | License scarcity plus platform readiness |
| Personal care / private duty (under $3M EBITDA) | 5.5x to 7.5x | Recruitment efficiency, private-pay share |
| Personal care / private duty ($5M+ platforms) | 7.5x to 10x and above | Multi-state footprint, payer diversity |
| Hospice | 9x to 13x, premium platforms above 14x | Census stability, predictable length of stay |
Scale changes the conversation. Crossing from a single-market regional agency into a multi-state platform with diversified payers and a clean compliance record can move you from the lower band into the higher one. That is why the same agency can be worth meaningfully more to a strategic platform buyer than to a first-time local acquirer. If you want a grounded starting estimate before any conversation, the ValueMyBusiness valuation calculator gives you a range in a few minutes.
See where your agency lands. Get a fast, confidential range with the ValueMyBusiness calculator, then talk it through with a healthcare-only advisor who has closed deals in home health. Run your valuation or start a confidential conversation.
Which value drivers raise your multiple the most?
The value drivers that move a home health multiple the most are payer mix, margin durability, staffing stability, star ratings, referral diversity, and clean financials, roughly in that order for most agencies. These are the levers a buyer can underwrite with confidence, which is why they translate directly into price.
Payer mix. Payer mix is often the single largest driver of an agency’s multiple. A book weighted toward stable, well-reimbursed payers with limited concentration reads as lower risk than one exposed to a single Medicare Advantage plan that can reprice at renewal. Buyers model the downside, so the agency that shows a balanced, resilient payer base defends a higher number.
Margin durability. Buyers care less about a single strong year than about whether the margin holds. Sustainable adjusted EBITDA, supported by real staffing levels rather than deferred hiring, survives diligence. Margins inflated by one-time items or stretched add-backs get renegotiated at the letter of intent.
Staffing stability. Caregiver turnover across the sector ran roughly 75 to 80 percent in 2026, with about 70 percent of new hires leaving within their first 100 days, per ShiftCare’s 2026 retention data. Replacement costs alone can consume 10 to 18 percent of revenue. An agency that holds turnover below 50 percent removes a major source of post-close risk, and buyers pay a premium for that de-risking because it protects the census they are buying.
Star ratings and compliance. A strong CMS star rating works as a direct financial multiplier, and a clean survey history with no open ADRs and no active audit findings removes the escrow and reserve set-asides a cautious buyer would otherwise carve out of your proceeds. In a market where buyers are selective, a spotless compliance posture is one of the cheapest ways to protect net cash at close.
Referral diversification. Referrals spread across many hospitals, physician groups, and facilities are transferable. Referrals that live inside the owner’s personal relationships are not, at least not reliably, and buyers discount them accordingly. Documenting and institutionalizing your referral sources is one of the highest-return moves available before a sale.
What red flags make buyers lower their offer or walk away?
The red flags that most often cut an offer are owner dependency, referral concentration, compliance exposure, high turnover, messy add-backs, and revenue concentration. Any one of these can shave a turn off the multiple. Two or three together can end a process before it reaches a letter of intent.
- Owner dependency. If the agency cannot run a week without you, the buyer is purchasing a job, not a business, and prices it that way.
- Referral concentration. One or two sources driving most admissions, especially sources tied to you personally, is the risk buyers fear most because it can leave with you.
- Compliance exposure. Open ADRs, a RAC audit in progress, or an unresolved survey finding invites escrow holdbacks and, in some cases, a pause on the whole deal.
- Elevated turnover. Staffing gaps that leave referrals unstaffed cap growth and signal that the reported margin may not be repeatable.
- Aggressive add-backs. Personal expenses run through the business are normal to a point, but a quality-of-earnings review will strip anything that will not recur, and an overstated EBITDA base erodes trust.
- Revenue concentration. A large share of revenue from a single contract, facility, or geography narrows the buyer pool and pulls the number down.
The encouraging part is that every item on that list is fixable with enough runway. Most owners come to us later than they should, but there is almost always time to move at least a few of these from the penalty column to the reward column before going to market.
Not sure which red flags apply to your agency? A confidential readiness conversation with Vallexa gives you an honest read before a buyer ever sees your books. Talk with a healthcare-only advisor.
How do I prepare my home health agency for sale?
Preparing a home health agency for sale means turning the six things buyers reward into documented, verifiable facts before you go to market. The steps below follow the order most owners find workable, and each one raises value on its own even if you decide to wait.
- Clean up the financials. Move to accrual-based statements, separate personal expenses, and build a defensible adjusted EBITDA schedule you can support line by line.
- Document your referral sources. Map every source, its volume, and its relationship owner, then start shifting relationships from personal to institutional.
- Reduce owner dependency. Delegate clinical, billing, and sales functions so the agency demonstrably runs without you for weeks at a time.
- Stabilize staffing. Track turnover honestly, fix the biggest drivers, and aim to bring turnover below the sector norm before diligence.
- Tidy your compliance posture. Resolve open ADRs, close out audit items, and protect your CMS star rating, since a clean record removes escrow risk.
- Diversify revenue. Reduce concentration in any single payer, contract, or geography so the earnings base looks resilient.
- Assemble a data room. Gather licenses, surveys, payer contracts, financials, org charts, and policies so diligence moves quickly when a buyer is engaged.
- Get a valuation and engage a healthcare-only advisor. Start with a grounded range, then work with an advisor who runs a confidential, competitive process rather than shopping you to one buyer.
If you want the full sequence with the diligence detail, our walkthrough of the seven steps to selling covers the process end to end, and ExitStrategies is a useful resource on timing and succession planning.
Should you sell your home health agency now or wait?
The honest answer is that the right time to sell is when your agency is prepared and your personal goals align, not when a headline tells you to. As of July 2026, the market backdrop is constructive: the proposed rule reduced reimbursement uncertainty, well-capitalized platforms are actively acquiring, and buyer demand for clean, de-risked agencies remains strong even as total deal count has cooled. That combination tends to favor prepared sellers.
The mistake we see most often is waiting to prepare until the decision to sell is already made. Most owners come to us 6 to 9 months later than they should, which compresses the window to fix the value drivers that matter. Even if your sale is 12 to 24 months out, the preparation work pays for itself in a higher multiple and a cleaner process. Starting early costs you nothing and protects your optionality. Buyer appetite is real right now, and anonymized buyer demand across the market is easy to gauge through platforms like Exits.ai. If you would rather have a person walk you through where you stand, that is exactly the conversation we have every week.
Frequently asked questions
What is my home health agency worth in 2026?
Most Medicare-certified home health agencies traded at about 7x to 10x adjusted EBITDA in non-CON markets and 9x to 12x in CON states as of the second quarter of 2026, per Mertz Taggart. Your specific number depends on payer mix, margins, staffing, compliance, and referral durability, so treat any range as a starting point rather than a quote.
What is the 36-month Medicare rule?
The 36-month rule generally requires that if a home health agency changes majority ownership within 36 months of enrollment or its last change of ownership, the buyer must enroll as a new agency and obtain a new state survey and Medicare certification rather than simply assuming the seller’s billing privileges. It affects deal structure and timing, so factor it into any sale conversation and confirm the current requirements with qualified counsel.
Do CMS star ratings really change my agency’s value?
Yes. A strong CMS star rating acts as a direct financial multiplier because it signals quality, supports referral flow, and reduces the compliance risk a buyer prices in. A high rating paired with a clean survey history is one of the more reliable ways to defend a premium.
What caregiver turnover rate do buyers consider good?
With the sector running roughly 75 to 80 percent turnover in 2026, an agency holding turnover below 50 percent stands out and de-risks the transition for a buyer. Lower, well-documented turnover supports both the reported margin and the census the buyer is acquiring, which helps hold the multiple.
How do add-backs affect my sale price?
Legitimate add-backs, such as genuinely non-recurring costs or documented owner perks, raise adjusted EBITDA and therefore your price. Aggressive or undocumented add-backs get removed during a quality-of-earnings review and can damage buyer trust, so it pays to be conservative and well-supported.
Who buys home health agencies right now?
Active buyers include private-equity-backed platforms, strategic regional and national operators, and, at the larger end, take-private sponsors. Recent examples of scale include Kinderhook Industries’ $1.1 billion take-private of Enhabit and General Atlantic’s roughly $3 billion acquisition of TEAM Services Group, both among the largest home-based care deals on record.
How long does it take to sell a home health agency?
A well-run, confidential process commonly takes about 6 to 9 months from preparation to close, and longer where the 36-month rule or a new survey requirement applies. Agencies that prepared their financials, compliance, and data room in advance move faster and hit fewer surprises in diligence.
About the author
Jason Atty is the founder of Vallexa Advisors, a healthcare-only mergers and acquisitions advisory firm focused on home health, hospice, and home care. Jason and the Vallexa team advise agency owners on valuation, preparation, and confidential sale processes designed to attract qualified buyers while protecting the operator’s confidentiality. Vallexa works on 100 percent success-based fees, with a healthcare-only focus, NDA-gated buyer disclosure, and a nationwide buyer network. Learn more about the firm’s work with skilled agencies on the home health advisory page.
Ready to see what your home health agency could be worth? Start with a confidential valuation range, then have a calm, numbers-led conversation about your options and your timing. There is no obligation and no upfront fee. Get your valuation or request a confidential consultation with Vallexa Advisors.
Related resources
- Home Health Agency Valuation in 2026: What It’s Worth
- When to Sell a Home Health Agency
- The 7 Steps to Selling Your Agency
- ValueMyBusiness Valuation Calculator
Educational only. Not legal, financial, or tax advice. Healthcare M&A outcomes depend on specific facts, payer mix, market conditions, and regulatory context. Speak with qualified counsel before acting on anything in this document.
Key Takeaways
- In 2026, buyers prioritize durable, transferable cash flow when evaluating home health agencies.
- Key factors buyers consider include payer mix, margin durability, staffing stability, compliance, referral diversification, and owner independence.
- The recent CMS proposed rule stabilizes buyer underwriting but does not eliminate all risks for home health agencies.
- To maximize value, prepare by organizing financials, documenting referral sources, and reducing owner dependency.
- Red flags for buyers include owner dependency, referral concentration, compliance issues, and high turnover rates.
Estimated reading time: 13 minutes
